Free Trial
NASDAQ:BGLC

BioNexus Gene Lab (BGLC) Stock Price, News & Analysis

BioNexus Gene Lab logo
$0.29 0.00 (0.00%)
(As of 11/22/2024 ET)

About BioNexus Gene Lab Stock (NASDAQ:BGLC)

Key Stats

Today's Range
$0.29
$0.31
50-Day Range
$0.29
$0.45
52-Week Range
$0.28
$3.39
Volume
100,989 shs
Average Volume
81,787 shs
Market Capitalization
$5.23 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers. Its products are used to produce handrails, bench tops, automotive and aero parts, and paneling for hospital, laboratory, industrial clean rooms, and covers for various instruments used in manufacturing. The company also involves in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers to detect potential risk of diseases. It markets its products through its website, warehouse, marketing personnel, and suppliers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

Receive BGLC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioNexus Gene Lab and its competitors with MarketBeat's FREE daily newsletter.

BGLC Stock News Headlines

BioNexus Gene Lab Faces Delisting and Leadership Changes
First JFK… next Elon?
Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.
BioNexus partners with Vitarray for gene detection
European Central Bank cuts key interest rates as inflation falls
See More Headlines

BGLC Stock Analysis - Frequently Asked Questions

BioNexus Gene Lab's stock was trading at $0.53 at the beginning of 2024. Since then, BGLC stock has decreased by 45.1% and is now trading at $0.2912.
View the best growth stocks for 2024 here
.

BioNexus Gene Lab (BGLC) raised $5 million in an initial public offering (IPO) on Thursday, July 20th 2023. The company issued 1,300,000 shares at a price of $4.00 per share. Network 1 Financial Securities acted as the underwriter for the IPO.

Shares of BGLC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that BioNexus Gene Lab investors own include Sangamo Therapeutics (SGMO), NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Adobe (ADBE), Arista Networks (ANET) and e.l.f. Beauty (ELF).

Company Calendar

Today
11/23/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical laboratories
Sub-Industry
Healthcare
Current Symbol
NASDAQ:BGLC
Fax
N/A
Employees
30
Year Founded
N/A

Profitability

Net Income
$-2,630,000.00
Pretax Margin
-9.93%

Debt

Sales & Book Value

Annual Sales
$9.77 million
Book Value
$0.52 per share

Miscellaneous

Free Float
17,605,000
Market Cap
$5.23 million
Optionable
Not Optionable
Beta
7.71
10 Best Stocks to Own in 2025 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:BGLC) was last updated on 11/24/2024 by MarketBeat.com Staff
From Our Partners